Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series

Blood-Brain Barrier Molecular Trojan Horse Enables Imaging of Brain Uptake of Radioiodinated Recombinant Protein in the Rhesus Monkey

(2013) Ruben J. Boado et al.   BIOCONJUGATE CHEMISTRY

Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls

(2012) Barbara K. Burton et al.   EUROPEAN JOURNAL OF PEDIATRICS

The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus

(2011) Joseph Muenzer et al.   EUROPEAN JOURNAL OF PEDIATRICS

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease

(2011) Maurizio Scarpa et al.   Orphanet Journal of Rare Diseases

THE NATURAL HISTORY OF THE SEVERE FORM OF HUNTER'S SYNDROME: A STUDY BASED ON 52 CASES

(2010) I. D. Young et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

(2010) Joseph Muenzer et al.   GENETICS IN MEDICINE

Respiratory Manifestations in Mucopolysaccharidoses

(2010) Marianne S. Muhlebach et al.   Paediatric Respiratory Reviews

Enzyme Replacement Therapy for Mucopolysaccharidoses: Opinions of Patients and Families

(2008) David J. Coman et al.   JOURNAL OF PEDIATRICS

Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)

(2008) R. Martin et al.   PEDIATRICS